Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025

The Market Herald

04-04

The ASX has been down 1.5% at 7,739 points this morning.

There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.

Staples and Health Care are the only sectors in positive territory so far.

In company news, Mesoblast (ASX:MSB) has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.

Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.

And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.

More market news

Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”

Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst

Join the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2524478612"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2524478612\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2524478612?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-04 09:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2524478612","market":"us","top_or_hot":-1,"title":"Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025","media":"The Market Herald","content":"<html><body><div>\n<p>The ASX has been down 1.5% at 7,739 points this morning.</p>\n<p>There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.</p>\n<p>Staples and Health Care are the only sectors in positive territory so far.</p>\n<p>In company news, Mesoblast (ASX:MSB) has been among the most watched on <em>HotCopper </em>forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.</p>\n<p>Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.</p>\n<p>And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.</p>\n<figure><div>\n<div></div>\n</div></figure>\n<p><strong><em>More market news</em></strong></p>\n<p><strong><em>Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”</em></strong></p>\n<p><strong><em>Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst</em></strong></p>\n<p><strong>Join the discussion:</strong> See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.</p>\n<p><em>The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click</em> <em>here</em>.</p>\n</div></body></html>","source":"markerherald_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Friday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFriday’s HotCopper Trends: Mesoblast dodges tariffs, Orthocell’s FDA tick | April 4, 2025\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">The Market Herald</strong><span class=\"h-time small\">2025-04-04 09:57</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><div>\n<p>The ASX has been down 1.5% at 7,739 points this morning.</p>\n<p>There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.</p>\n<p>Staples and Health Care are the only sectors in positive territory so far.</p>\n<p>In company news, Mesoblast (ASX:MSB) has been among the most watched on <em>HotCopper </em>forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.</p>\n<p>Orthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.</p>\n<p>And, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.</p>\n<figure><div>\n<div></div>\n</div></figure>\n<p><strong><em>More market news</em></strong></p>\n<p><strong><em>Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”</em></strong></p>\n<p><strong><em>Meet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst</em></strong></p>\n<p><strong>Join the discussion:</strong> See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.</p>\n<p><em>The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click</em> <em>here</em>.</p>\n</div></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://themarketonline.com.au/fridays-hotcopper-trends-mesoblast-dodges-tariffs-orthocells-fda-tick-april-4-2025-2025-04-04/\">The Market Herald</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7104","symbol_name":"黃金","start_time":0,"source_url":"https://themarketonline.com.au/fridays-hotcopper-trends-mesoblast-dodges-tariffs-orthocells-fda-tick-april-4-2025-2025-04-04/","article_id":"2524478612","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2524478612","pubTimestamp":1743731820,"columns":[],"sourceInfo":{"source_id":"markerherald_stock","name":"The Market Herald"},"weMediaInfo":null,"summary":"The ASX has been down 1.5% at 7,739 points this morning.There’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.Staples and Health Care are the only sectors in positive territory so far.In company news, Mesoblast  has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.Orthocell  has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.And, finally, Bellevue Gold  has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.Levy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”。The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research a","collect":0,"end_time":0,"defaultTopTitle":"themarketonline.com.au","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7104":"黄金","BK7501":"新冠治疗股","BK7508":"医药生物股","BK4139":"生物科技","BGL.AU":"BELLEVUE GOLD LTD","MESO":"Mesoblast Limited","BK7067":"生物科技","OCC.AU":"ORTHOCELL LTD","MSB.AU":"MESOBLAST LTD"},"translate_title":"周五热门铜趋势：Mesoblast逃避关税，Orthocell的FDA将于2025年4月4日公布","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BGL.AU":1,"MESO":1,"MSB.AU":1,"OCC.AU":1},"content_text":"The ASX has been down 1.5% at 7,739 points this morning.\nThere’s been carnage on the ASX and the Energy sector has been enduring a bloodbath, followed by IT and Utilities.\nStaples and Health Care are the only sectors in positive territory so far.\nIn company news, Mesoblast (ASX:MSB) has been among the most watched on HotCopper forums today after the medicinal company confirmed its belief its products will not be subject to United States tariffs.\nOrthocell (ASX:OCC) has also been trending on news the US FDA has given the green light for the company’s nerve repair product, Remplir, to be sold in the States.\nAnd, finally, Bellevue Gold (ASX:BGL) has provided an update saying it’s not yet in a position to make an announcement about the potential downward adjustment to its FY25 production guidance.\n\n\n\nMore market news\nLevy beef: Trump whacks Oz with 10% tariffs on “Liberation Day”\nMeet GeoGeorge: The HotCopper poster so accurate he got hired as an analyst\nJoin the discussion: See what’s trending right now on Australia’s largest stock forum and be part of the conversations that move the markets.\nThe material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1}}}